VC23 Ventures — Seed & Series A VC Firm
VC23 Ventures is a Seed, Series A, Series B venture capital firm investing in Other, AI / ML, Developer Tools. The firm has 12 portfolio companies in our records.
- Portfolio
- 12 companies on record
- Partners
- 1 listed
- Stage
- Seed, Series A, Series B
- Sectors
- Other, AI / ML, Developer Tools
- Check size
- Not in our records
- AUM
- Not in our records
Last verified: 2026-09-01
Seed, Series A, Series B
12+ companies
1 partner
Investment Thesis
Biotools-focused fund backing companies that power modern biotech—from next-generation research tools to data and AI automation platforms, with a core focus on life-science tools and diagnostics.
How VC23 Ventures invests
VC23 Ventures is a vc firm. The firm invests at the Seed, Series A, Series B stages, with a focus on Other, AI / ML, Developer Tools.
VC23 Ventures has backed 12 companies in our records, including CellSonic, Codetta Bio, Enrich Biosystems.
Partners & Team
Investment Team (not individually listed)
General Partner
Industry Focus
Invests In
Portfolio Companies (12)
Other
CellSonic
develops non-invasive bioelectric shockwave devices to stimulate cell repair, wound healing, and cancer treatment without drugs or surgery.
Codetta Bio
develops integrated multiplexed assays combining DNA, RNA, and protein detection to enable comprehensive, high-throughput molecular diagnostics and precision medicine.
Enrich Biosystems
develops advanced cell isolation and enrichment technologies that improve recovery, purity, and viability for single-cell and proteomic applications.
Fluent Bio
enables high-throughput single-cell RNA sequencing using scalable, instrument-free barcoding.
Intus Bio
develops molecular diagnostic tools and point-of-care platforms to enable rapid, accessible detection of infectious and genetic diseases.
ProteoWise
revolutionizes proteomics with HyperBlot, an automated multiplexed platform delivering rapid, quantitative protein analysis.
Talee Bio
developed AAV gene therapies for cystic fibrosis, targeting airway cells to restore CFTR function.
10x Genomics
develops single-cell and spatial biology tools that enable high-resolution molecular profiling for biomedical research and discovery.
Bactana
was a Cornell University spinoff at the forefront of anaerobic fermentation and the isolation of postbiotic molecules produced by commensal bacteria in the microbiome.
Bastion Health
delivers a telehealth platform focused exclusively on men’s health, combining at-home tests with virtual urologist visits and personalized care navigation.
- •Raising at Seed, Series A, Series B? You're squarely in their sweet spot.
- •Lead with your fit in Other, AI / ML, Developer Tools — the sectors they actively back.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Investment Team (not individually listed), General Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if VC23 Ventures is a match for your startup
Upload your pitch deck to see how well you match with VC23 Ventures and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal